Canada · Delayed Price · Currency is CAD Ventripoint Diagnostics Company Description
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.
The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
Contact Details
Address: 18 Hook Avenue Toronto, ON M6P 1T4 Canada | |
| Phone | 416 848 4156 |
| Website | ventripoint.com |
Stock Details
| Ticker Symbol | VPT |
| Exchange | TSX Venture Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA92281P2008 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Hugh MacNaught | Chief Executive Officer, President and Director |
| Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. | Executive Chairman and Corporate Secretary |
| David Swetlow C.A., CPA | Chief Financial Officer |
| Hirotaka Katagiri | Chief Technology Officer and Business Development Division Director |
| Matt Dobson | Marketing Director |
| Jim Graba | Application Specialist and Chief Trainer |